TY - JOUR
T1 - Comparison of the requirements for hepatic injury with halothane and enflurane in rats
AU - Lind, R. C.
AU - Gandolfi, A. J.
AU - Sipes, I. G.
AU - Brown, B. R.
PY - 1985
Y1 - 1985
N2 - A rat model of enflurane-associated hepatotoxicity was compared with the halothane-hypoxia (HH) model (adult male rats, phenobarbital induction, 1% halothane, 14% O2, for 2 hr). The enflurane-hypoxia heating (EHH) model involved exposing phenobarbital-pretreated male adults rats to 1.5-1.8% enflurane at 10% O2 for 2 hr with external heating to help maintain body temperature. Exposure to either anesthetic without temperature support led to a decrease in body temperature of 7-9°C, while heating the animals during anesthesia resulted in only a 0.5-2°C decrease. Reducing the oxygen tension to 10% O2 combined with heating the animals during exposure produced significant decreases in the oxidative metabolism of both halothane and enflurane as compared to exposures of 14% O2. The same conditions also caused a significant increase in the reductive metabolism of halothane, indicating that a severe hepatic hypoxia or anoxia occurs during anesthesia at 10% O2 with external heating. The time course of lesion development in the HH model paralleled results obtained with an oral dose of CCl4L: gradual progression of necrosis up to 24 hr. EHH resulted in a classic hypoxic/anoxic injury with elevated serum glutamate pyruvate transaminase values and a watery vascuolization of centrilobular hepatocytes immediately after exposure. The HH model required phenobarbital pretreatment of the rats for expression of hepatic injury; EHH did not. Heating of the animals during anesthesia exposure was necessary for enflurane-induced hepatotoxicity but had little effect on the HH model in both requirements for and type of hepatic injury. Thus the HH model appears to act via a bioactivation/chemotoxic mechanism, whereas models of anesthetic-induced hepatotoxicity that require very low oxygen tensions and heating of the animals during exposure result from a severe hypoxia/anoxia of the liver.
AB - A rat model of enflurane-associated hepatotoxicity was compared with the halothane-hypoxia (HH) model (adult male rats, phenobarbital induction, 1% halothane, 14% O2, for 2 hr). The enflurane-hypoxia heating (EHH) model involved exposing phenobarbital-pretreated male adults rats to 1.5-1.8% enflurane at 10% O2 for 2 hr with external heating to help maintain body temperature. Exposure to either anesthetic without temperature support led to a decrease in body temperature of 7-9°C, while heating the animals during anesthesia resulted in only a 0.5-2°C decrease. Reducing the oxygen tension to 10% O2 combined with heating the animals during exposure produced significant decreases in the oxidative metabolism of both halothane and enflurane as compared to exposures of 14% O2. The same conditions also caused a significant increase in the reductive metabolism of halothane, indicating that a severe hepatic hypoxia or anoxia occurs during anesthesia at 10% O2 with external heating. The time course of lesion development in the HH model paralleled results obtained with an oral dose of CCl4L: gradual progression of necrosis up to 24 hr. EHH resulted in a classic hypoxic/anoxic injury with elevated serum glutamate pyruvate transaminase values and a watery vascuolization of centrilobular hepatocytes immediately after exposure. The HH model required phenobarbital pretreatment of the rats for expression of hepatic injury; EHH did not. Heating of the animals during anesthesia exposure was necessary for enflurane-induced hepatotoxicity but had little effect on the HH model in both requirements for and type of hepatic injury. Thus the HH model appears to act via a bioactivation/chemotoxic mechanism, whereas models of anesthetic-induced hepatotoxicity that require very low oxygen tensions and heating of the animals during exposure result from a severe hypoxia/anoxia of the liver.
UR - http://www.scopus.com/inward/record.url?scp=0022358008&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022358008&partnerID=8YFLogxK
U2 - 10.1213/00000539-198510000-00003
DO - 10.1213/00000539-198510000-00003
M3 - Article
C2 - 4037395
AN - SCOPUS:0022358008
SN - 0003-2999
VL - 64
SP - 955
EP - 963
JO - Anesthesia and analgesia
JF - Anesthesia and analgesia
IS - 10
ER -